View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Rubicon Organics Acquires Hope Facility to Accelerate Premium Cannabis...

Rubicon Organics Acquires Hope Facility to Accelerate Premium Cannabis Growth Strategy VANCOUVER, British Columbia, June 05, 2025 (GLOBE NEWSWIRE) -- June 5, 2025 – Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics”, “Rubicon” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis products, today announced the closing of its acquisition of an operational, purpose-built 47,500 sq. ft. indoor cultivation facility in Hope, British Columbia. The acquisition is a key milestone in Rubicon’s growth strategy to expand pr...

 PRESS RELEASE

Rubicon Organics Reports Q1 2025 Financial and Operating Results

Rubicon Organics Reports Q1 2025 Financial and Operating Results Achieved net revenue of $12.4 million, representing a 39.2% increase compared to the same quarter in prior yearGenerated Adjusted EBITDA1 of $0.7 million, an improvement of $1.1 million year-over-yearRemoved conditions precedent for the purchase of the Hope Facility, advancing strategic expansion plansCompleted a private placement for aggregate gross proceeds of $4.5 million VANCOUVER, British Columbia, May 27, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Compa...

 PRESS RELEASE

Rubicon Organics Clears Conditions for Hope Facility Acquisition, Adva...

Rubicon Organics Clears Conditions for Hope Facility Acquisition, Advancing Growth Strategy VANCOUVER, British Columbia, May 22, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis products, is pleased to announce the removal of all conditions precedent, related to its previously announced purchase and sale agreement (the “PSA”) with Medipharm Labs Inc. for an operational, purpose-built 47,500 square foot indoor cultivation facility in...

 PRESS RELEASE

Rubicon Organics to Report Q1 2025 Results

Rubicon Organics to Report Q1 2025 Results VANCOUVER, British Columbia, May 15, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis products, is pleased to announce that it will be reporting its financial results for the three months ended March 31, 2025 (“Q1 2025”) after market close on Tuesday, May 27, 2025. The Company will be hosting a conference call to discuss Q1 2025 results on Wednesday, May 28, 2025. Conference call details a...

 PRESS RELEASE

Rubicon Organics Announces Appointment of Glen Ibbott as Interim CFO

Rubicon Organics Announces Appointment of Glen Ibbott as Interim CFO VANCOUVER, British Columbia, May 15, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis products, today announced the appointment of Glen Ibbott, a cannabis industry veteran and former Chief Financial Officer of Aurora Cannabis Inc. (TSX: ACB, Nasdaq: ACB) as its Interim Chief Financial Officer. Janis Risbin, current CFO, will be stepping away from her full-time rol...

 PRESS RELEASE

Rubicon Organics Announces Closing of Private Placement Offering under...

Rubicon Organics Announces Closing of Private Placement Offering under the Listed Issuer Financing Exemption NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 07, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis products, is pleased to announce it has closed its previously announced non-brokered private placement offering under the listed issuer fina...

 PRESS RELEASE

Rubicon Organics Announces Upsize of Private Placement Offering under ...

Rubicon Organics Announces Upsize of Private Placement Offering under the Listed Issuer Financing Exemption NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, April 30, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis products, is pleased to announce that due to market demand, the Company has increased the size of its previously announced non-brokered pr...

 PRESS RELEASE

Rubicon Organics annonce l’augmentation de la taille du placement priv...

Rubicon Organics annonce l’augmentation de la taille du placement privé sous le régime de la dispense pour financement de l’émetteur coté NE PAS DISTRIBUER AUX SERVICES DE FIL DE PRESSE AMÉRICAINS NI DIFFUSER AUX ÉTATS-UNIS VANCOUVER, Colombie-Britannique, 30 avr. 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV : ROMJ) (OTCQX : ROMJF) (« Rubicon Organics » ou la « Société »), un producteur autorisé axé sur la culture et la vente de produits de cannabis de première qualité certifié biologique, est heureuse d’annoncer que, compte tenu de la demande du marché, la Société a augmenté l...

 PRESS RELEASE

Cannara Biotech Delivers Record Q2 Results as National Expansion Accel...

Cannara Biotech Delivers Record Q2 Results as National Expansion Accelerates Record Revenue: Net revenues of $26.6 million in Q2 2025, a 35% increase compared to $19.7 million in Q2 2024, driven by national brand growth and product innovation.Record Profitability: Gross profit before fair value adjustments rose 52% to $10.8 million in Q2 2025 from $7.1 million in Q2 2024, with gross margins improving to 41%.Strong Adjusted EBITDA: Delivered sixteenth consecutive quarter of positive Adjusted EBITDA, more than doubling to a record $7.1 million, up 102% from Q2 20241.Expanding Market Presence:...

 PRESS RELEASE

Cannara Biotech affiche des résultats record au deuxième trimestre et ...

Cannara Biotech affiche des résultats record au deuxième trimestre et accélère son expansion nationale Revenus records : Revenus nets de 26,6 millions de dollars au deuxième trimestre de 2025, soit une augmentation de 35 % par rapport aux 19,7 millions de dollars du deuxième trimestre de 2024, grâce à la croissance nationale de la marque et à l’innovation de produits.Rentabilité record : La marge brute avant ajustements de la juste valeur a augmenté de 52 % pour atteindre 10,8 millions de dollars au deuxième trimestre 2025, contre 7,1 millions de dollars au deuxième trimestre 2024, les marg...

 PRESS RELEASE

Cannara Biotech Inc. annoncera ses résultats financiers pour le deuxiè...

Cannara Biotech Inc. annoncera ses résultats financiers pour le deuxième trimestre de l'exercice 2025 le 28 avril 2025 MONTRÉAL, 16 avr. 2025 (GLOBE NEWSWIRE) -- (« Cannara », « la Société », « nous » ou « notre ») () () (), producteur verticalement intégré de cannabis de qualité supérieure et de produits dérivés à des prix abordables, disposant de deux méga-installations au Québec d’une superficie de plus de 1 650 000 pieds carrés, a annoncé aujourd'hui qu'elle publiera ses résultats pour le deuxième trimestre clos le 28 février 2025 le lundi 28 avril 2025, à 7h00 (heure de l'Est). Le...

 PRESS RELEASE

Cannara Biotech Inc. to Announce Fiscal Q2 2025 Financial Results on A...

Cannara Biotech Inc. to Announce Fiscal Q2 2025 Financial Results on April 28, 2025 MONTREAL, April 16, 2025 (GLOBE NEWSWIRE) -- (“Cannara”, “the Company”, “us” or “we”) () () (), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft., today announced that it will release its financial results for the second quarter ended February 28, 2025, on Monday, April 28, 2025, at 7:00 a.m. ET. Cannara Biotech’s CFO, Nicholas Sosiak, will host an earnings webcast o...

 PRESS RELEASE

Rubicon Organics Announces Proposed Private Placement Offering under t...

Rubicon Organics Announces Proposed Private Placement Offering under the Listed Issuer Financing Exemption NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, April 15, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis products, is pleased to announce a non-brokered private placement offering of up to 6,818,182 units of the Company (each, a “Unit”) for aggre...

 PRESS RELEASE

Rubicon Organics to Present at The Planet MicroCap Showcase in Las Veg...

Rubicon Organics to Present at The Planet MicroCap Showcase in Las Vegas, NV and at ICBC Berlin B2B in Berlin, Germany VANCOUVER, British Columbia, April 11, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), is Canada’s leading premium licensed producer focused on cultivating and selling organic certified and premium cannabis products and ultra-premium products, is pleased to announce its upcoming participation in two industry events: the Planet MicroCap Showcase: VEGAS 2025, taking place April 22–24, 2025, at the Paris Hotel...

 PRESS RELEASE

Rubicon Organics Reports 2024 Financial Results

Rubicon Organics Reports 2024 Financial Results Highlights for the fourth quarter ended December 31, 2024 and subsequent events: Record high net revenue of $14.2 million, an increase of 42% from Q4 2023Achieved Adjusted EBITDA1 of $1.6 million (including $0.25 million of one-time ERP costs)Achieved positive operating cashflows of $2.3 million and Free Cash Flows2 of $1.8 millionSecured $10 million credit facilities at interest rate of 6.75% for 5 yearsEntered into purchase and sale agreement for Hope, BC facility, expanding capacity of premium flower by 40%3Secured key ...

Nicholas Cortellucci ... (+2)
  • Nicholas Cortellucci
  • CFA

Taking Another Look at Cannabis Stocks

What you need to know: • Sentiment for cannabis stocks remains at all time lows with the MSOS and MJ ETFs down 95% and 93% respectively from their highs. • We believe there are solid names in the sector that have formidable growth and expanding margins albeit the tough pricing environment. • The sector trades at historically low multiples, with the Canadian LPs at 7.3x 2025E EBITDA and MSOs at 6.5x. • We review the regulatory changes over the last few years as well as what is in the pipeline fo...

 PRESS RELEASE

Cannara Biotech Announces Appointment of Justin Cohen to Board of Dire...

Cannara Biotech Announces Appointment of Justin Cohen to Board of Directors MONTREAL, March 24, 2025 (GLOBE NEWSWIRE) -- (“Cannara”, “the Company”, “us” or “we”) () () (), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft., is pleased to announce the appointment of Mr. Justin Cohen to its board of directors (the “Board”) as an independent director. Mr. Cohen will also serve as a member of the Audit Committee. Mr. Cohen is a seasoned executive with a trac...

 PRESS RELEASE

Cannara Biotech annonce la nomination de Justin Cohen au conseil d’adm...

Cannara Biotech annonce la nomination de Justin Cohen au conseil d’administration MONTRÉAL, 24 mars 2025 (GLOBE NEWSWIRE) --  (« Cannara », la « Société », « nous » ou « notre ») () () (), producteur verticalement intégré de cannabis de qualité supérieure et de produits dérivés à des prix abordables, disposant de deux méga-installations au Québec d’une superficie de plus de 1 650 000 pieds carrés, a le plaisir d’annoncer la nomination de M. Justin Cohen au sein de son conseil d’administration en tant qu’administrateur indépendant. M. Cohen sera également membre du Comité d’audit. M. Cohe...

 PRESS RELEASE

Rubicon Organics to Report Q4 2024 Results

Rubicon Organics to Report Q4 2024 Results VANCOUVER, British Columbia, March 18, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis products, is pleased to announce that it will be reporting its financial results for the year ended December 31, 2024 (“Q4 2024”) after market close on Tuesday, April 1, 2025. The Company will be hosting a conference call to discuss Q4 2024 results on Wednesday, April 2, 2025. Conference call details ar...

 PRESS RELEASE

Rubicon Organics Marks Milestone with First-Ever International Shipmen...

Rubicon Organics Marks Milestone with First-Ever International Shipment VANCOUVER, British Columbia, March 13, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics”, “Rubicon”, or the “Company”), Canada’s leading premium licensed producer focused on cultivating and selling organic certified, premium and super-premium cannabis products, announces its first international shipment of premium dried flower to Poland. This milestone marks the first time Rubicon’s high-quality products are available to international customers. As demand for cannabis cont...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch